FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/16/2022
Back to search
Official data from USPTO
FEMCHECK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
FEMCHECK
ST13
US500000079299178Class
5, 9, 35, 42
Filing
79299178
Registration
6541669
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
05/16/2022
Trademark type
Word
Nice classes
5, 9, 35, 42
Filing date
05/26/2020
Registration date
11/02/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/02/2021
Last transaction
11/02/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Palmerston North, NZ
Examiner
CAYSIDO, REBECCA
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SCIENCE HAVEN LIMITED
Representatives
Kazuyo Morita Holland & Hart LLP
Technical classification
Nice Classes
Class 5Class 9Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoringnamely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoringnamely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto track ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females
Class 9
Downloadable software and downloadable mobile applications for use with non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; Downloadable software and downloadable mobile applications for testing and tracking urinary metabolitesin particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females
Class 35
Retail and wholesale store services for non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoringnamely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for chemical diagnostic reagents and assays for medical purposes for use in diagnostic in vitro test kits for home use in the field of fertility monitoringnamely medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto track ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for use with non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoringnamely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for downloadable software and downloadable mobile applications for testing and tracking urinary metabolitesin particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services featuring software for use with non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoringnamely kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; retail and wholesale store services for software as a service (SAAS) services for testing and tracking urinary metabolitesin particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; online advertising and marketing services in relation to the aforementioned goods
Class 42
Software as a service (SAAS) services featuring software for use with non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; software as a service (SAAS) services featuring software for testing and tracking urinary metabolitesin particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for use with non-prescriptionover the counterdiagnostic in vitro test kits for home use in the field of fertility monitoring in particular with kits comprised of medical diagnostic reagents and assays to monitor urinary metabolites in particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto quantitate urinary based assays to monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females; providing temporary use of online non-downloadable computer software for testing and tracking urinary metabolitesin particular estrogen metabolitesprogesterone metabolitescortisol metabolites and testosterone metabolitesto monitor ovulation and ovarian activityto identify ovulation dates and to identify fertility periods of females
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/22/2022
FIMP
FINAL DISPOSITION PROCESSED
04/22/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/02/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/17/2021
PUBO
PUBLISHED FOR OPPOSITION
08/17/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/15/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/28/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/13/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/13/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/13/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/13/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/16/2021
ATRV
ATTORNEY REVIEW COMPLETED
03/23/2021
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
03/23/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/28/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2021
RFNT
REFUSAL PROCESSED BY IB
01/11/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/16/2020
RFRR
REFUSAL PROCESSED BY MPU
12/16/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/08/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/08/2020
CNRT
NON-FINAL ACTION WRITTEN
12/07/2020
DOCK
ASSIGNED TO EXAMINER
12/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/04/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/03/2020
Continuous trademark protection
Get notified about every new filing that threatens FEMCHECK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.